Shield TX (UK) Ltd., a subsidiary of Maru AG, is a company headquartered in Gateshead, UK. The firm provides clinical trials. It was founded in 2008.

Cognetix, Inc. discovered and developed drugs. Its products were used for the treatment of epilepsy, local anesthesia, heart disease, stroke, neuromuscular back pain, multiple sclerosis, and spinal cord injury. The company was founded in 1996 by Dennis B. Farrar, Baldomero M. Olivera and J. Michael McIntosh and was headquartered in Salt Lake City, UT

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

Oslo University Hospital (Norwegian: Oslo universitetssykehus) is a university hospital in Oslo, Norway. With over 24,000 employees it is the largest hospital in Northern Europe. It is affiliated with the Faculty of Medicine of the University of Oslo and is one of the largest medical research institutions in Europe. It was established in 2009, and is a result of the merger of the then-three university hospitals in Oslo.

Clinical Genomics Pty Ltd. develops and delivers healthcare products for early detection and prevention of disease. The company is headquartered in North Ryde, Australia.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

NicOx is a biopharmaceutical company, engages in the development and commercialization of nitric oxide (NO)-donating drugs primarily for inflammation and cardio-metabolic diseases. The company's primary products candidates include Naproxcinod, a Phase III product candidate for the treatment of osteoarthritis; and NCX 6560, a NO-donating compound for the treatment of cardiovascular diseases, which is in phase I clinical trials. Its product portfolio comprise PF-03187207 for the treatment of glaucoma, TPI 1020 for the treatment of respiratory disorders, and NCX 1510 for allergic rhinitis, which are in Phase II clinical trials; and NO-donating antihypertensives, which is in phase I clinical trials for the treatment of hypertension. The company's product pipeline also include NCX 1047, which is in preclinical stage of development for treating a range of skin disorders, such as atopic dermatitis, psoriasis, and seborrheic dermatitis; and NO-donors for diabetic retinopathy, cardiometabolic, inflammation, and pain. It has research and co-development agreement with Orexo AB to identify and develop compounds for the treatment of airway diseases; license and development agreement with TOPIGEN Pharmaceuticals Inc. The company also has agreements with Grupo Ferrer Internacional SA for the research, development, and marketing of NO-donating anti-inflammatory drugs for the treatment of dermatological diseases; Pfizer Inc to identify nitric oxide-donating compounds for diabetic retinopathy; and Merck & Co., for the development of new antihypertensive drugs using NicOx' nitric oxide-donating technology. NicOx S.A. was founded in 1996 and is headquartered in Sophia Antipolis, France.

UK Research & Innovation (doing business as United Kingdom Research & Innovation) is a private company headquartered in London, UK. The firm provides science and technology research services.\nThe company says this about itself: Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government. We drive productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base.

Shanghai Nanotechnology and Application National Engineering Research Center Co., Ltd., established on 2004-08-20, Business scope includes research and development of nanotechnology and related technologies,Production and sales of nano-related products,Technology development in the nanosphere,technology transfer,technical consulting,Technical Services,Investment in projects and products,account Serive. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Nantong Tingchuan Electronic Technology Co., Ltd., established on 2017-12-15, Business scope includes electronic product development,Sales;Office Equipment Sales;Development of computer software and hardware,Sales;Technology development in the computer field,technology transfer,technical consulting,Technical Services;Intellectual property agency;marketing planning;Corporate Image Planning;Technology project agency service..(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Pharmacia & Upjohn AB is a private company headquartered in Stockholm, Sweden. The firm manufactures pharmaceutical drugs.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Junxi Biotechnology (Shanghai) Co., Ltd., established on 2019-11-29, Business scope includes biotechnology,Technology development in the field of chemical science and technology,technical consulting,technology transfer,Technical Services;Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Instrumentation,Electrical Equipment,electronic product,cleaning tools,Anti-labor supplies,Daily necessities,Stationery,plastic products,laboratory equipment,Wholesale and retail of Class I medical devices;business inquiries;account Serive;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.]

Vetica Labs is operating in the healthcare industry focusing on the biotechnology business. It was founded in 2013 and is based in San Diego, California.